PDF herunterladen
Am J Perinatol 2018; 35(14): 1443-1448
DOI: 10.1055/s-0038-1660463
Commentary
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Rationale for In-Neonatal Intensive Care Unit Administration of Live, Attenuated Rotavirus Vaccination

Courtney Briggs-Steinberg
1   Division of Newborn Medicine, Maria Fareri Children's Hospital, Valhalla, New York
,
Shetal Shah
1   Division of Newborn Medicine, Maria Fareri Children's Hospital, Valhalla, New York
› Institutsangaben Funding None.
Weitere Informationen

Publikationsverlauf

18. August 2017

19. April 2018

Publikationsdatum:
08. Juni 2018 (online)

    Lizenzen und Reprints

Abstract

Rotavirus is the most common nonseasonal vaccine preventable illness. Despite increased severity of rotaviral illness in early infancy, most neonatal intensive care units (NICU) do not administer rotavirus vaccination either during the NICU stay at age of eligibility or at discharge as the Advisory Committee on Immunization Practices recommends. In this commentary, we review the rationale for the administration of rotavirus vaccination to premature infants. Further, we outline data supporting vaccine administration at chronologic age while still admitted to the NICU.

Keywords

rotavirus - immunization - NICU - premature infants
 

  • References

  • 1 Dennehy PH. Rotavirus vaccines--an update. Vaccine 2007; 25 (16) 3137-3141
    CrossrefPubMedGoogle Scholar
  • 2 Payne DC, Staat MA, Edwards KM. , et al. Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States. Pediatrics 2008; 122 (06) 1235-1243
    CrossrefPubMedGoogle Scholar
  • 3 Widdowson MA, Meltzer MI, Zhang X, Bresee JS, Parashar UD, Glass RI. Cost-effectiveness and potential impact of rotavirus vaccination in the United States. Pediatrics 2007; 119 (04) 684-697
    CrossrefPubMedGoogle Scholar
  • 4 Cortes JE, Curns AT, Tate JE. , et al. Rotavirus vaccine and health care utilization for diarrhea in U.S. children. N Engl J Med 2011; 365 (12) 1108-1117
    CrossrefPubMedGoogle Scholar
  • 5 Clark HF, Marcello AE, Lawley D, Reilly M, DiNubile MJ. Unexpectedly high burden of rotavirus gastroenteritis in very young infants. BMC Pediatr 2010; 10 (40) 40
    CrossrefPubMedGoogle Scholar
  • 6 Zhou F, Shefer A, Wenger J. , et al. Economic evaluation of the routine childhood immunization program in the United States, 2009. Pediatrics 2014; 133 (04) 577-585
    CrossrefPubMedGoogle Scholar
  • 7 Leshem E, Tate JE, Steiner CA, Curns AT, Lopman BA, Parashar UD. National estimates of reductions in acute gastroenteritis-related hospitalizations and associated costs in US children after implementation of rotavirus vaccines. J Pediatric Infect Dis Soc 2017; 35 (14) 1-4
    PubMedGoogle Scholar
  • 8 Crawford SE, Ramani S, Tate JE. , et al. Rotavirus infection. Nat Rev Dis Primers 2017; 3: 17083
    CrossrefPubMedGoogle Scholar
  • 9 Roué J-M, Nowak E, Le Gal G. , et al. Impact of rotavirus vaccine on premature infants. Clin Vaccine Immunol 2014; 21 (10) 1404-1409
    CrossrefPubMedGoogle Scholar
  • 10 Dennehy PH, Cortese MM, Bégué RE. , et al. A case-control study to determine risk factors for hospitalization for rotavirus gastroenteritis in U.S. children. Pediatr Infect Dis J 2006; 25 (12) 1123-1131
    CrossrefPubMedGoogle Scholar
  • 11 Goveia MG, Rodriguez ZM, Dallas MJ. , et al; REST Study Team. Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants. Pediatr Infect Dis J 2007; 26 (12) 1099-1104
    CrossrefPubMedGoogle Scholar
  • 12 Newman RD, Grupp-Phelan J, Shay DK, Davis RL. Perinatal risk factors for infant hospitalization with viral gastroenteritis. Pediatrics 1999; 103 (01) E3
    CrossrefPubMedGoogle Scholar
  • 13 Bresee JS, Glass RI, Ivanoff B, Gentsch JR. Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries. Vaccine 1999; 17 (18) 2207-2222
    CrossrefPubMedGoogle Scholar
  • 14 Sharma R, Hudak ML, Premachandra BR. , et al. Clinical manifestations of rotavirus infection in the neonatal intensive care unit. Pediatr Infect Dis J 2002; 21 (12) 1099-1105
    CrossrefPubMedGoogle Scholar
  • 15 Shim JO, Son DW, Shim SY, Ryoo E, Kim W, Jung YC. Clinical characteristics and genotypes of rotaviruses in a neonatal intensive care unit. Pediatr Neonatol 2012; 53 (01) 18-23
    CrossrefPubMedGoogle Scholar
  • 16 Rotbart HA, Levin MJ, Yolken RH, Manchester DK, Jantzen J. An outbreak of rotavirus-associated neonatal necrotizing enterocolitis. J Pediatr 1983; 103 (03) 454-459
    CrossrefPubMedGoogle Scholar
  • 17 Rotbart HA, Nelson WL, Glode MP. , et al. Neonatal rotavirus-associated necrotizing enterocolitis: case control study and prospective surveillance during an outbreak. J Pediatr 1988; 112 (01) 87-93
    CrossrefPubMedGoogle Scholar
  • 18 Linhares AC, Mascarenhas JD, Gusmão RH, Gabbay YB, Fialho AM, Leite JP. Neonatal rotavirus infection in Belém, northern Brazil: nosocomial transmission of a P[6] G2 strain. J Med Virol 2002; 67 (03) 418-426
    CrossrefPubMedGoogle Scholar
  • 19 Committee on Infectious Diseases; American Academy of Pediatrics. Prevention of rotavirus disease: updated guidelines for use of rotavirus vaccine. Pediatrics 2009; 123 (05) 1412-1420
    CrossrefPubMedGoogle Scholar
  • 20 Cortese MM, Parashar UD. ; Centers for Disease Control and Prevention (CDC). Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2009; 58 (RR-2): 1-25
    PubMedGoogle Scholar
  • 21 Rha B, Tate JE, Weintraub E. , et al. Intussusception following rotavirus vaccination: an updated review of the available evidence. Expert Rev Vaccines 2014; 13 (11) 1339-1348
    CrossrefPubMedGoogle Scholar
  • 22 Shui IM, Baggs J, Patel M. , et al. Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants. JAMA 2012; 307 (06) 598-604
    PubMedGoogle Scholar
  • 23 Rotarix, rotavirus vaccine, live, oral [package insert]. Oral suspension, initial US approval; 2008. Available at: https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/ Prescribing_Information/Rotarix/pdf/ROTARIX-PI-PIL.PDF . Accessed January 12, 2018
    PubMedGoogle Scholar
  • 24 Shah S. Immunization issues in preterm infants: pertussis, influenza, rotavirus. Neoreviews 2014; 15 (10) e439-e446
    CrossrefPubMedGoogle Scholar
  • 25 Hofstetter AM, Lacombe K, Klein EJ. , et al. Risk of rotavirus nosocomial spread after inpatient pentavalent rotavirus vaccination. Pediatrics 2018; 141 (01) e20171110
    CrossrefPubMedGoogle Scholar
  • 26 Stumpf KA, Thompson T, Sánchez PJ. Rotavirus vaccination of very low birth weight infants at discharge from the NICU. Pediatrics 2013; 132 (03) e662-e665
    CrossrefPubMedGoogle Scholar
  • 27 Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR. , et al; Human Rotavirus Vaccine Study Group. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354 (01) 11-22
    CrossrefPubMedGoogle Scholar
  • 28 Vesikari T, Matson DO, Dennehy P. , et al; Rotavirus Efficacy and Safety Trial (REST) Study Team. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006; 354 (01) 23-33
    CrossrefPubMedGoogle Scholar
  • 29 Omenaca F, Sarlangue J, Szenborn L. , et al; ROTA-054 Study Group. Safety, reactogenicity and immunogenicity of the human rotavirus vaccine in preterm European Infants: a randomized phase IIIb study. Pediatr Infect Dis J 2012; 31 (05) 487-493
    CrossrefPubMedGoogle Scholar
  • 30 Smith CK, McNeal MM, Meyer NR, Haase S, Dekker CL. Rotavirus shedding in premature infants following first immunization. Vaccine 2011; 29 (45) 8141-8146
    CrossrefPubMedGoogle Scholar
  • 31 Anderson EJ. Rotavirus vaccines: viral shedding and risk of transmission. Lancet Infect Dis 2008; 8 (10) 642-649
    CrossrefPubMedGoogle Scholar
  • 32 Clark HF, Bernstein DI, Dennehy PH. , et al. Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants. J Pediatr 2004; 144 (02) 184-190
    CrossrefPubMedGoogle Scholar
  • 33 Monk HM, Motsney AJ, Wade KC. Safety of rotavirus vaccine in the NICU. Pediatrics 2014; 133 (06) e1555-e1560
    CrossrefPubMedGoogle Scholar
  • 34 Nallu LA, Ehrenkranz R, Vazquez M. Impact of length of neonatal intensive care unit hospitalization on receipt of rotavirus vaccine. Poster presented at Annual Meeting of the Pediatric Academic Society; Apr 30-May 03, 2016; Baltimore, MD. Abstract 1521.586
    PubMedGoogle Scholar
  • 35 Fang AY, Tingay DG. Early observations in the use of oral rotavirus vaccination in infants with functional short gut syndrome. J Paediatr Child Health 2012; 48 (06) 512-516
    CrossrefPubMedGoogle Scholar
  • 36 Javid PJ, Sanchez SE, Jacob S, McNeal MM, Horslen SP, Englund JA. The safety and immunogenicity of rotavirus vaccination in infants with intestinal failure. J Pediatric Infect Dis Soc 2014; 3 (01) 57-65
    CrossrefPubMedGoogle Scholar
  • 37 Hiramatsu H, Suzuki R, Nagatani A. , et al. Rotavirus vaccination can be performed without viral dissemination in the Neonatal Intensive Care Unit. J Infect Dis 2018; 217 (04) 589-596
    CrossrefPubMedGoogle Scholar
  • 38 National Center for Health Statistics. final natality data. Available at: www.marchofdimes.org/peristats . Accessed June 7th, 2017
    PubMed
  • 39 Skowronski DM, Janjua NZ, Tsafack EP, Ouakki M, Hoang L, De Serres G. The number needed to vaccinate to prevent infant pertussis hospitalization and death through parent cocoon immunization. Clin Infect Dis 2012; 54 (03) 318-327
    CrossrefPubMedGoogle Scholar
  • 40 Saari TN. ; American Academy of Pediatrics Committee on Infectious Diseases. Immunization of preterm and low birth weight infants. Pediatrics 2003; 112 (1 Pt 1): 193-198
    CrossrefPubMedGoogle Scholar
  • 41 Jaques SC, Ogley L, Duffy D, Kennea N. Rotavirus immunisation in NICU: a 1-year experience in a UK tertiary neonatal surgical unit postvaccine introduction. Arch Dis Child Fetal Neonatal Ed 2015; 100 (02) F186-F187
    PubMedGoogle Scholar
  • 42 Kilich E, Anthony M. Rotavirus vaccination in preterm infants: a neonatal guidance chart to aid timely immunisation. Arch Dis Child Fetal Neonatal Ed 2015; 100 (05) F465
    PubMedGoogle Scholar
  • 43 Thrall S, Doll MK, Nhan C. , et al. Evaluation of pentavalent rotavirus vaccination in neonatal intensive care units. Vaccine 2015; 33 (39) 5095-5102
    CrossrefPubMedGoogle Scholar